Skip to main content
. 2011 Aug 9;105(6):746–752. doi: 10.1038/bjc.2011.310

Table 2. Cox regression analysis of patient features, NHS Trust trial entry and the patient's receipt of chemotherapy on overall survival.

  Total patients (N=7782) Deaths (N=6981) %a Unadjusted HR Adjusted HRb P-value c
Sex
 Male 4206 3838 91     <0.001
 Female 3576 3143 88 0.84 (0.80, 0.88) 0.86 (0.82, 0.90)  
             
Age quintile (years)
 1 (30–62) 2161 1859 86     <0.001
 2 (63–69) 1917 1731 90 1.22 (1.14, 1.30) 1.12 (1.04, 1.21)  
 3 (70–75) 1757 1561 89 1.31 (1.23, 1.40) 1.20 (1.11, 1.30)  
 4 (76–80) 1159 1079 93 1.62 (1.51, 1.75) 1.31 (1.19, 1.44)  
 5 (81–101) 788 751 95 2.07 (1.90, 2.25) 1.47 (1.32, 1.64)  
             
Performance status
 PS 0 975 772 79     <0.001
 PS 1 1919 1653 86 1.39 (1.28, 1.52) 1.34 (1.24, 1.45)  
 PS 2 1437 1344 94 2.19 (2.01, 2.40) 1.83 (1.67, 2.00)  
 PS 3 868 847 98 3.82 (3.46, 4.21) 2.65 (2.36, 2.99)  
 PS 4 269 265 99 8.63 (7.40, 9.95) 5.01 (4.05, 6.19)  
 Missing 2314 2100 91 1.86 (1.71, 2.02) 1.63 (1.50, 1.77)  
             
Stage
 Limited 1319 1043 79     0.001
 Extensive 3053 2894 95 2.45 (2.28, 2.63) 2.07 (1.92, 2.25)  
 Missing 3410 3044 89 1.74 (1.62, 1.87) 1.43 (1.31, 1.57)  
             
Townsend quintile
 1 (Most affluent) 1075 947 88     0.341
 2 1378 1234 90 1.04 (0.96, 1.13) 1.07 (0.98, 1.17)  
 3 1523 1365 90 1.08 (0.99, 1.17) 1.07 (0.97, 1.17)  
 4 1650 1490 90 1.05 (0.97, 1.14) 1.07 (0.98, 1.18)  
 5 (Least affluent) 2138 1929 90 1.05 (0.97, 1.13) 1.07 (0.96, 1.19)  
 Missing 18 16 89 1.13 (0.69, 1.85) 1.52 (1.15, 2.02)  
             
Ethnic group
 White 6015 5439 90     0.422
 Black 31 26 84 0.71 (0.49, 1.05) 0.79 (0.56, 1.11)  
 Asian 396 344 87 1.06 (0.95, 1.19) 1.01 (0.88, 1.15)  
 Mixed 14 11 79 0.69 (0.38, 1.24) 0.78 (0.47, 1.31)  
 Other 37 32 87 1.00 (0.71, 1.42) 0.84 (0.46, 1.52)  
 Missing 1289 1129 88 1.00 (0.93, 1.06) 1.04 (0.94, 1.14)  
             
Charlson index
 0 3466 3015 87     <0.001
 1 1483 1301 88 1.23 (1.15, 1.32) 1.07 (1.01, 1.14)  
 2 or 3 1080 967 90 1.35 (1.25, 1.45) 1.11 (1.02, 1.22)  
 4+ 1753 1698 97 2.09 (1.97, 2.22) 1.62 (1.49, 1.77)  
             
Chemotherapy
 No 2967 2825 95     <0.001
 Yes 4815 4156 86 0.43 (0.41, 0.45) 0.51 (0.46, 0.56)  
             
Trial entry (%)
 <5 5282 4739 90     0.83
 >5 2500 2242 90 0.96 (0.91, 1.01) 0.99 (0.88, 1.10)  

Abbreviations: HR=hazard ratio; NHS=National Health Service.

a

Percentage of patients from each subgroup who have died.

b

HR adjusted for all other variables in the table. Analysis clustered by the NHS Trust features.

c

All non-binary variables are tested for trend except ethnicity, which is a likelihood ratio test.

All missing values were removed prior to the calculation of probability.

A total of 63 patients had a date of diagnosis on or before their date of death, and were excluded from survival analyses (N=7782).